Quantification in pet: What is it? can we do it? do we need it?

Nuclear Medicine Communications

Volumn 25, Issue 7, 2004, Pages 635-636

  Marsden, Paul K ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; COMPUTER ASSISTED DIAGNOSIS; EDITORIAL; IMAGE ENHANCEMENT; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; CLINICAL PROTOCOL; CONFERENCE PAPER; DEVICE; HYPOXIA; IMAGING SYSTEM; INDUSTRY; QUANTITATIVE ANALYSIS; STANDARDIZATION;

ALGORITHMS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; POSITRON-EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE; TRACER;

EID: 16644393370     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000134326.08041.af     Document Type: Article

References (9)

1. Visvikis D, Turzo A, Bizais Y, Cheze-Le Rest C. Technology related parameters affecting quantification in PET imaging. Nucl Med Commun 2004; 25:637-641.
2. Cunningham VJ, Gunn RN, Matthews JC. Quantification in PET for research in pharmacology and drug development. Nucl Med Commun 2004; 25:643-646.
3. Hallett WA. Quantification in clinical FDG PET. Nucl Med Commun 2004; 25:647-650.
4. Lucignani G, Paganelli G, Bombardieri E. On the use of standard uptake values for assessing FDG uptake with PET in oncology: a clinical perspective. Nucl Med Commun 2004; 25:651-656.
5. Friston KJ, Holmes AP, Worsley KJ, Poline J-B, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping 1995; 2:189-210.
6. 18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods. Mol Imaging Biol 2003; 5:337-346.
7. 18F]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations. Eur J Cancer 1999; 35:1773-1782.
8. Laruelle M. The role of model-based methods in the development of single scan techniques. Nucl Med Biol 2000; 27:637-642.
9. Van den Abbeele AD, Badawi RD. Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs). Eur J Cancer 2002; 38:S60-S65.